FIELD: medicine.
SUBSTANCE: invention can be used for prevention of local recurrence after transanal endoscopic resection of rectum cancer in patients with initial forms of rectal cancer T1N0M0. For this purpose during the surgical intervention, after a full thickness resection of the intestinal wall with a part of mezorectal cellular tissue and removal of the preparation the mezorectal cellular tissue is infiltrated with 20 ml of ozonised physiologic saline in the ratio of 1000 mcg/l. Then a preparation of interferon alpha 1 is introduced into the mezorectal cellular tissue in the amount of 1 million IU. After that the mezorectal cellular tissue is sprayed with 1 g of capecitabine powder. Then, at the following stage, the rectal wall is closed in a standard way.
EFFECT: method provides for reduction of a rate of local disease recurrence.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREVENTION OF INFECTIOUS-INFLAMMATORY COMPLICATIONS OF TRANSANAL ENDOSCOPIC RESECTION OF RECTUM FOR TUMOURS | 2015 |
|
RU2578811C1 |
METHOD FOR ORGAN-PRESERVING TREATMENT OF OPERABLE RECTAL CANCER | 2020 |
|
RU2740361C1 |
HYBRID TRANSANAL RECTAL RESECTION METHOD | 2018 |
|
RU2698852C2 |
METHOD FOR CORRECTING THE PROLAPSE OF THE MUCOUS LAYER OF THE RECTUM | 2022 |
|
RU2788805C1 |
METHOD FOR TREATING BIG VILLOUS TUMORS OF INFERIOR AMPULLATE AREA OF THE RECTUM | 2000 |
|
RU2169533C1 |
METHOD FOR FORMING TRANSANAL LOW COLORECTAL ANASTOMOSIS DURING SURGICAL TREATMENT OF PATIENTS WITH RECTAL CANCER | 2023 |
|
RU2804594C1 |
METHOD OF MODIFIED CHEMICAL TREATMENT OF COLORECTAL CANCER | 2018 |
|
RU2678642C1 |
METHOD OF NEOADJUVANT THERMOCHEMORADIATION TREATMENT OF RECTAL CANCER | 2018 |
|
RU2704205C2 |
METHOD FOR TREATING LOW-LYING TUMORS OF RECTUM AND ANAL CANAL | 2017 |
|
RU2666694C1 |
METHOD FOR PREVENTING DEVELOPMENT OF MANIFESTED LOW ANTERIOR RESECTION SYNDROME | 2024 |
|
RU2820326C1 |
Authors
Dates
2016-03-27—Published
2015-02-17—Filed